A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients

[Image: see text] Introduction Coronavirus disease (COVID-19) pandemic has started to affect Saudi Arabia in the beginning of March 2020 and is expected to cause significant morbidity to many patients, especially to elderly, who might require intensive care unit (ICU) support to survive as its letha...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Hashmi, Hani, Alawami, Deia, Zaidi, Syed Ziauddin A, Alshehry, Nawal F, Alzahrani, Hazza A., Zaidi, Abdul Rehman Z, Al Sagheir, Ahmed, Khojah, Osamah, Alaskar, Ahmed, AlMozain, Noura, Al-Ansari, Rehab, Alfaraj, Mona, ElGohary, Ghada, Dayel, Afra, Bahrani, Ahmed, Abdulhamid, Arwa Nabhan, Alhumaidan, Hind, Albalawi, Mohammed, AlFraedhi, Alia, Al-Otaibi, Jawaher, Abdallah, Rania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330310/
http://dx.doi.org/10.1182/blood-2020-138496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330310/
http://dx.doi.org/10.1182/blood-2020-138496

Ejemplares similares